Phase I study of MP-101 in healthy volunteers.
Latest Information Update: 30 Jun 2020
At a glance
- Drugs MP 101 (Primary)
- Indications Huntington's disease
- Focus Adverse reactions
- Sponsors Mitochon Pharmaceuticals
- 30 Jun 2020 Status changed from planning to recruiting, according to a Mitochon Pharmaceuticals company pipeline.
- 05 Mar 2019 According to a Mitochon Pharmaceuticals media release, this trial is expected to initiate in 2019.
- 03 Oct 2017 According to a Mitochon Pharmaceuticals media release, this trial is expected to initiate in 2018.